These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 16374251)

  • 1. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases.
    Pierik M; Joossens S; Van Steen K; Van Schuerbeek N; Vlietinck R; Rutgeerts P; Vermeire S
    Inflamm Bowel Dis; 2006 Jan; 12(1):1-8. PubMed ID: 16374251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis.
    Franchimont D; Vermeire S; El Housni H; Pierik M; Van Steen K; Gustot T; Quertinmont E; Abramowicz M; Van Gossum A; Devière J; Rutgeerts P
    Gut; 2004 Jul; 53(7):987-92. PubMed ID: 15194649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.
    Papp M; Altorjay I; Norman GL; Shums Z; Palatka K; Vitalis Z; Foldi I; Lakos G; Tumpek J; Udvardy ML; Harsfalvi J; Fischer S; Lakatos L; Kovacs A; Bene L; Molnar T; Tulassay Z; Miheller P; Veres G; Papp J; ; Lakatos PL
    Inflamm Bowel Dis; 2007 Aug; 13(8):984-92. PubMed ID: 17417801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common NOD2/CARD15 and TLR4 Polymorphisms Are Associated with Crohn's Disease Phenotypes in Southeastern Brazilians.
    Tolentino YF; Elia PP; Fogaça HS; Carneiro AJ; Zaltman C; Moura-Neto R; Luiz RR; Carvalho Mda G; de Souza HS
    Dig Dis Sci; 2016 Sep; 61(9):2636-47. PubMed ID: 27107867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population.
    Gazouli M; Mantzaris G; Kotsinas A; Zacharatos P; Papalambros E; Archimandritis A; Ikonomopoulos J; Gorgoulis VG
    World J Gastroenterol; 2005 Feb; 11(5):681-5. PubMed ID: 15655821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
    Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
    Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between toll-like receptors/CD14 gene polymorphisms and inflammatory bowel disease in Korean population.
    Kim EJ; Chung WC; Lee KM; Paik CN; Jung SH; Lee BI; Chae HS; Choi KY
    J Korean Med Sci; 2012 Jan; 27(1):72-7. PubMed ID: 22219617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease.
    Rigoli L; Romano C; Caruso RA; Lo Presti MA; Di Bella C; Procopio V; Lo Giudice G; Amorini M; Costantino G; Sergi MD; Cuppari C; Calabro GE; Gallizzi R; Salpietro CD; Fries W
    World J Gastroenterol; 2008 Jul; 14(28):4454-61. PubMed ID: 18680223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association and phenotypic correlation of TLR4 but not NOD2 variants with Tunisian inflammatory bowel disease.
    Feki S; Bouzid D; Abida O; Chtourou L; Elloumi N; Toumi A; Hachicha H; Amouri A; Tahri N; Masmoudi H
    J Dig Dis; 2017 Nov; 18(11):625-633. PubMed ID: 29055077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
    Fernandes P; MacSharry J; Darby T; Fanning A; Shanahan F; Houston A; Brint E
    Clin Exp Immunol; 2016 Mar; 183(3):358-68. PubMed ID: 26462859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients.
    Riis L; Vind I; Vermeire S; Wolters F; Katsanos K; Politi P; Freitas J; Mouzas IA; O'Morain C; Ruiz-Ochoa V; Odes S; Binder V; Munkholm P; Moum B; Stockbrügger R; Langholz E;
    Inflamm Bowel Dis; 2007 Jan; 13(1):24-32. PubMed ID: 17206636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort.
    Bank S; Andersen PS; Burisch J; Pedersen N; Roug S; Galsgaard J; Ydegaard Turino S; Brodersen JB; Rashid S; Kaiser Rasmussen B; Avlund S; Bastholm Olesen T; Hoffmann HJ; Andersen Nexø B; Sode J; Vogel U; Andersen V
    PLoS One; 2015; 10(12):e0145302. PubMed ID: 26698117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
    Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
    Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for association of OCTN genes and IBD5 with ulcerative colitis.
    Waller S; Tremelling M; Bredin F; Godfrey L; Howson J; Parkes M
    Gut; 2006 Jun; 55(6):809-14. PubMed ID: 16361305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
    Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis.
    Palmieri O; Latiano A; Valvano R; D'Incà R; Vecchi M; Sturniolo GC; Saibeni S; Peyvandi F; Bossa F; Zagaria C; Andriulli A; Devoto M; Annese V
    Aliment Pharmacol Ther; 2006 Feb; 23(4):497-506. PubMed ID: 16441470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
    Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
    Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants at the 3p21 locus influence susceptibility and phenotype both in adults and early-onset patients with inflammatory bowel disease.
    Latiano A; Palmieri O; Corritore G; Valvano MR; Bossa F; Cucchiara S; Castro M; Riegler G; De Venuto D; D'Incà R; Andriulli A; Annese V
    Inflamm Bowel Dis; 2010 Jul; 16(7):1108-17. PubMed ID: 20024904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.